RecruitingNot ApplicableNCT07288047

Virtual Reality as a Method for Pain and Anxiety Control During First Trimester Procedural Abortion

Virtual Reality as an Adjunctive Agent for the Management of Pain and Anxiety During First Trimester Procedural Abortion: a Randomized Controlled Trial


Sponsor

Study Investigator

Enrollment

72 participants

Start Date

May 1, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this clinical trial is to learn whether use of a virtual reality (VR) headset showing a meditative nature video will help reduce pain and anxiety during a first trimester procedural abortion. Investigators will enroll 72 patients undergoing a first trimester procedural abortion with usual care to manage pain and anxiety compared to use of a VR headset in addition to usual care to see if use of the VR headset will decrease pain and anxiety and increase satisfaction with the procedure.


Eligibility

Sex: FEMALEMin Age: 18 Years

Inclusion Criteria6

  • Patients at Planned Parenthood of Western Pennsylvania who have decided to undergo and are eligible for a procedural abortion.
  • years old or older
  • <14 weeks gestation on day of abortion
  • Able to comprehend written English
  • Willing to comply with the study protocol
  • Willing and able to provide informed consent

Exclusion Criteria8

  • History of vertigo
  • History of epilepsy
  • Claustrophobia
  • Significant hearing or visual impairments (such as deafness or blindness)
  • Require hearing aids
  • Have an implanted medical device, such as cardiac pacemaker or defibrillator
  • Require misoprostol for cervical preparation
  • Prior unsuccessful attempt at abortion during this pregnancy

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEVR headset

VR Headset: Meta Quest 3S Meditative nature videos provided via "Guided Meditation VR" app.

OTHERUsual Care

Usual care for pain and anxiety management during a first trimester procedural abortion includes oral ibuprofen, intracervical block, and verbal analgesia.


Locations(2)

Center for Family Planning Research, Magee-Womens Hospital

Pittsburgh, Pennsylvania, United States

Planned Parenthood of Western Pennsylvania

Pittsburgh, Pennsylvania, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07288047


Related Trials